
Cheryl Willman MD
Anatomic Pathology, Clinical Pathology
Professor, Pathology, University of New Mexico School of Medicine
Join to View Full Profile
2325 Camino de Salud NEUNM Cancer Research Treatment CenterAlbuquerque, NM 87131
Phone+1 505-272-5622
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Cheryl Willman, MD is a board certified pathologist in Albuquerque, New Mexico. She is currently licensed to practice medicine in New Mexico. She is a Professor at University of New Mexico School of Medicine.
Education & Training
University of New Mexico School of MedicineResidency, Pathology-Anatomic and Clinical, 1981 - 1984
Mayo Clinic College of Medicine and Science (Rochester)Residency, Pathology-Anatomic and Clinical, 1981 - 1981
Mayo Clinic College of MedicineClass of 1981
Certifications & Licensure
NM State Medical License 1985 - 2028
American Board of Pathology Anatomic Pathology
Publications & Presentations
PubMed
- Reply to: Accurate Determinants of Outcome in ALL.Ti-Cheng Chang, Wenan Chen, Chunxu Qu, Zhongshan Cheng, Abdelrahman Elsayed
Journal of Clinical Oncology. 2025-03-10 - Proteogenomic characterization of highly enriched viable leukemic blasts in acute myeloid leukemia: A SWOG report.Jasmine Naru, Megan Othus, ChenWei Lin, Melinda A Biernacki, Marie Bleakley
Ejhaem. 2024-12-01 - 2 citationsOvercoming Systemic Barriers to Make Patient-Partnered Research a Reality.Vinayak Venkataraman, Bailey A Martin-Giacalone, Bettina F Drake, Liz Salmi, Elizabeth B Claus
Journal of Clinical Oncology. 2024-12-01
Press Mentions
Technology’s Changing Role in Cancer CareAugust 6th, 2025
Mayo Clinic Jacksonville Opens $320M Cancer CenterJune 16th, 2025
Mayo Clinic Takes the Next Step in Making Heavy Particle Therapy Available in the Western Hemisphere for Patients with Aggressive CancersJune 11th, 2025









